Study of Neoantigen mRNA Vaccines in Patients With Resectable Pancreatic Cancer
Study of Neoantigen mRNA Vaccines in Patients With Resectable Pancreatic Cancer
Recruiting · NCT06326736 · Registry updated 2024-03-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Neoantigen mRNA Vaccines in Patients With Resectable Pancreatic Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Recruiting | Early phase 1 | 2024-03-22 | NCT06326736 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Jiangsu Synthgene Biotechnology Co.Ltd. | 1 |
| Jinling Hospital, China | 33 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Wang Sizhen | Nanjing | China | 2 |